• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

MYL:US

48.2100 USD 0.4600 0.96%

As of 17:20:00 ET on 08/22/2014.

Snapshot for Mylan Inc/PA (MYL)

Open: 48.1500 Day's Range: 47.8700 - 49.0000 Volume: 2,788,468
Previous Close: 47.7500 52wk Range: 34.4600 - 57.5200 1-Yr Rtn: +35.50%

Stock Chart for MYL

No chart data available.
  • MYL:US 48.2100
  • 1D
  • 1M
  • 1Y
47.7500
Interactive MYL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MYL

Current P/E Ratio (ttm) 24.6540
Estimated P/E(12/2014) 14.5123
Relative P/E vs. SPX 1.3826
Earnings Per Share (USD) (ttm) 1.9555
Est. EPS (USD) (12/2014) 3.3220
Est. PEG Ratio 1.2345
Market Cap (M USD) 18,032.82
Shares Outstanding (M) 374.05
30 Day Average Volume 6,038,818
Price/Book (mrq) 5.4076
Price/Sale (ttm) 2.5443
Dividend Indicated Gross Yield -%
Cash Dividend (USD) -
Dividend Ex-Date 07/17/2007
5 Year Dividend Growth -
Next Earnings Announcement 10/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MYL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MYL

Mylan Inc. is a global generic and specialty pharmaceuticals company. The Company operates an active pharmaceutical ingredient manufacturer and runs a specialty business focused on respiratory, allergy, and psychiatric therapies.

Robert J CouryChairmanRodney L PiattVice Chairman
Heather BreschChief Executive OfficerRajiv MalikPresident
More Company Profile & Key Executives for MYL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil